Evidence map›Paper›PMID 34981813›Full record

ArticleMolecular medicine reports2022

Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations.

Anna Grenda, Agata A Filip, Ewa Wąsik-Szczepanek

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anna GrendaDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20‑059 Lublin, Poland.
Agata A FilipDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, 20‑059 Lublin, Poland.
Ewa Wąsik-SzczepanekDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20‑059 Lublin, Poland.
Medical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alterations in microRNA (miRNA/miRs) expression are associated with the occurrence and course of human diseases, including chronic lymphocytic leukemia (CLL). Expression of miRNAs may vary among patients with CLL in different cytogenetic risk groups. The present study assessed the expression levels of the following miRNAs in 35 patients with CLL: hsa‑miR‑15a, ‑16‑1, ‑29a, ‑29c, ‑34a, ‑34b, ‑155, ‑181a, ‑181b, ‑221, ‑222 and ‑223. Fluorescent

Indexed as

Chromosome AberrationsAgedChromosome DeletionDisease ProgressionFemaleHumansIn Situ Hybridization, FluorescenceLeukemia, Lymphocytic, Chronic, B-CellMaleMicroRNAsMiddle AgedRisk FactorsROC CurveTumor Suppressor Protein p53MicroRNAsTP53 protein, humanTumor Suppressor Protein p53chromosomal aberrationschronic lymphocytic leukemiamicroRNA

Identifiers

PMID34981813
PMCPMC8767551
OpenAlexW4205529197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.